Compare IMNM & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | TENB |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2020 | 2018 |
| Metric | IMNM | TENB |
|---|---|---|
| Price | $20.57 | $20.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 20 |
| Target Price | $32.80 | ★ $34.32 |
| AVG Volume (30 Days) | 906.1K | ★ 2.5M |
| Earning Date | 03-03-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | 3.23 |
| EPS | N/A | ★ N/A |
| Revenue | $6,941,000.00 | ★ $999,405,000.00 |
| Revenue This Year | $18.41 | $9.37 |
| Revenue Next Year | $863.23 | $7.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.04 |
| 52 Week Low | $5.15 | $17.28 |
| 52 Week High | $27.65 | $37.14 |
| Indicator | IMNM | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 46.74 |
| Support Level | $18.98 | $19.15 |
| Resistance Level | $22.57 | $21.29 |
| Average True Range (ATR) | 1.10 | 0.91 |
| MACD | -0.07 | 0.11 |
| Stochastic Oscillator | 25.75 | 68.07 |
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.